أرسل هذا في رسالة قصيرة: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _    _      ___    __    __   __   __    ______  
| |  | ||   / _ \\  \ \\ / //  \ \\/ //  /_   _// 
| |/\| ||  | / \ ||  \ \/ //    \ ` //   `-| |,-  
|  /\  ||  | \_/ ||   \  //      | ||      | ||   
|_// \_||   \___//     \//       |_||      |_||   
`-`   `-`   `---`       `        `-`'      `-`'